isoSolutions provides an integrated suite of products and services for nuclear medicine applications worldwide, including Radiochemicals, Radiopharmaceuticals, Stable isotopes, Sealed sources, Synthesizers, Shielding Equipment, Labeled compounds, and QC Instruments. We supply a diverse array of radioisotopes, including C-14, Cu-67, Ga-68 Generators, I-124, I-125, I-131, Lu-177, Mo-99, Sr-90, Tb-161, Tc-99m generators, Y-90 & Zr-89, Cyclotron products, and associated equipment. Additionally, we provide Stable Isotopes such as O18 Water, B-10, Ca-46, Cd-110, DZO (depleted ZnO), Gd-160, He-3, Mo-92, Mo-100, Ni-58, Ni-64, Rb-87, Re-185, Re-187, Si-29, Si-30, Te-124, Tl-203, W-182, W-183, W-184, Yb-176, Zr-90, Zn-68. Our offerings are complemented by an automated labeling module for development work or preprogrammed syntheses, a comprehensive line of QC instruments, and radiation shielding products.
In 2023, we proudly introduced the first set of products for solid target chemistry production, featuring a solid target station with a beamline isolation module. isoSolutions has approved and pending patent claims in various jurisdictions for these innovative products.
We also offer services for radiochemistry and formulation development, isotope production, first in-human, clinical trials ourselves or by using the services of our partner company- ORBITON THERAGNOSTICS.
We take great pride in our multicultural and globally dispersed sales and logistics team, strategically positioned across the world to serve our clientele efficiently and effectively.
